Altoida’s digital device is designed to measure and monitor neurocognitive function in people aged 55 and up with mild cognitive decline through the collection of “personalized brain data” from a 10-minute evaluation of immersive augmented reality and motor activities, administered via a smartphone or tablet. The device then leverages artificial intelligence to assess that brain data and predict if an individual will or will not develop Alzheimer’s within the coming year. The tech draws on two decades of dementia research, the company said in a recent press release.